Nordic Pharma

• Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe

  Phase 3, Completed, 278 people, 17 Sept 2015

• NCT02128243

  Collaborator, Phase 2, Completed, 242 people, 1 May 2014

Sources: clinicaltrials.gov